Selected research
Market Structure
Global Skin Active Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Skin Active Delivery System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Skin Active Delivery System include KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Corium, Nitto, Valeritas, Nanopass Technologies, TheraJect, Inc and Vaxxas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Skin Active Delivery System market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Skin Active Delivery System and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Skin Active Delivery System revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Skin Active Delivery System market size, projected growth trends, production technologies, key applications, and end-use industries.
Skin Active Delivery System Segment by Company
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Corium
Nitto
Valeritas
Nanopass Technologies
TheraJect, Inc
Vaxxas
Microdermics
Lohmann Therapie-Systeme AG
BASF
3M
Evonik Personal Care
Vantage Personal Care
Minerals Technologies
Bicosome
Skin Active Delivery System Segment by Type
Microcapsules
Base Oil
Microneedle Technology
Skin Active Delivery System Segment by Application
Drug
Cosmetic
Skin Active Delivery System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Active Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Skin Active Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Active Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Skin Active Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Skin Active Delivery System industry.
Chapter 3: Detailed analysis of Skin Active Delivery System companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Skin Active Delivery Systemrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microcapsules
- Base Oil
- Microneedle Technology
Applications
- Drug
- Cosmetic
Companies covered
- KINDEVA
- Zosano Pharma
- Becton-Dickinson(BD)Technologies
- Corium
- Nitto
- Valeritas
- Nanopass Technologies
- TheraJect, Inc
- Vaxxas
- Microdermics
- Lohmann Therapie-Systeme AG
- BASF
- 3M
- Evonik Personal Care
- Vantage Personal Care
- Minerals Technologies
- Bicosome
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Skin Active Delivery System Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Microcapsules
- 1.2.3 Base Oil
- 1.2.4 Microneedle Technology
- 1.3 Market Analysis by Application
- 1.3.1 Global Skin Active Delivery System Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drug
- 1.3.3 Cosmetic
- 1.4 Global Market Growth Prospects
- 1.5 Global Skin Active Delivery System Growth Trends by Region
- 1.5.1 Global Skin Active Delivery System Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Skin Active Delivery System Market Size by Region (2021-2026)
- 1.5.3 Skin Active Delivery System Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Skin Active Delivery System Market Dynamics
- 2.1 Skin Active Delivery System Industry Trends
- 2.2 Skin Active Delivery System Industry Drivers
- 2.3 Skin Active Delivery System Industry Opportunities and Challenges
- 2.4 Skin Active Delivery System Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Skin Active Delivery System Revenue by Company (2021-2026)
- 3.2 Global Skin Active Delivery System Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Skin Active Delivery System Key Company Head office and Area Served
- 3.4 Global Skin Active Delivery System Company, Product Type & Application
- 3.5 Global Skin Active Delivery System Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Skin Active Delivery System Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Skin Active Delivery System Players Market Share by Revenue in 2025
- 3.6.3 2025 Skin Active Delivery System Tier 1, Tier 2, and Tier 3
4 Skin Active Delivery System Market by Type
- 4.1 Global Skin Active Delivery System Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Skin Active Delivery System Market Size by Type (2021-2032)
- 4.3 Global Skin Active Delivery System Market Size Share by Type (2021-2032)
5 Skin Active Delivery System Market by Application
- 5.1 Global Skin Active Delivery System Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Skin Active Delivery System Market Size by Application (2021-2032)
- 5.3 Global Skin Active Delivery System Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 KINDEVA
- 6.1.1 KINDEVA Company Information
- 6.1.2 KINDEVA Business Overview
- 6.1.3 KINDEVA Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 KINDEVA Skin Active Delivery System Product Portfolio
- 6.1.5 KINDEVA Recent Developments
- 6.2 Zosano Pharma
- 6.2.1 Zosano Pharma Company Information
- 6.2.2 Zosano Pharma Business Overview
- 6.2.3 Zosano Pharma Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Zosano Pharma Skin Active Delivery System Product Portfolio
- 6.2.5 Zosano Pharma Recent Developments
- 6.3 Becton-Dickinson(BD)Technologies
- 6.3.1 Becton-Dickinson(BD)Technologies Company Information
- 6.3.2 Becton-Dickinson(BD)Technologies Business Overview
- 6.3.3 Becton-Dickinson(BD)Technologies Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Becton-Dickinson(BD)Technologies Skin Active Delivery System Product Portfolio
- 6.3.5 Becton-Dickinson(BD)Technologies Recent Developments
- 6.4 Corium
- 6.4.1 Corium Company Information
- 6.4.2 Corium Business Overview
- 6.4.3 Corium Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Corium Skin Active Delivery System Product Portfolio
- 6.4.5 Corium Recent Developments
- 6.5 Nitto
- 6.5.1 Nitto Company Information
- 6.5.2 Nitto Business Overview
- 6.5.3 Nitto Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Nitto Skin Active Delivery System Product Portfolio
- 6.5.5 Nitto Recent Developments
- 6.6 Valeritas
- 6.6.1 Valeritas Company Information
- 6.6.2 Valeritas Business Overview
- 6.6.3 Valeritas Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Valeritas Skin Active Delivery System Product Portfolio
- 6.6.5 Valeritas Recent Developments
- 6.7 Nanopass Technologies
- 6.7.1 Nanopass Technologies Company Information
- 6.7.2 Nanopass Technologies Business Overview
- 6.7.3 Nanopass Technologies Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Nanopass Technologies Skin Active Delivery System Product Portfolio
- 6.7.5 Nanopass Technologies Recent Developments
- 6.8 TheraJect, Inc
- 6.8.1 TheraJect, Inc Company Information
- 6.8.2 TheraJect, Inc Business Overview
- 6.8.3 TheraJect, Inc Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 TheraJect, Inc Skin Active Delivery System Product Portfolio
- 6.8.5 TheraJect, Inc Recent Developments
- 6.9 Vaxxas
- 6.9.1 Vaxxas Company Information
- 6.9.2 Vaxxas Business Overview
- 6.9.3 Vaxxas Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Vaxxas Skin Active Delivery System Product Portfolio
- 6.9.5 Vaxxas Recent Developments
- 6.10 Microdermics
- 6.10.1 Microdermics Company Information
- 6.10.2 Microdermics Business Overview
- 6.10.3 Microdermics Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Microdermics Skin Active Delivery System Product Portfolio
- 6.10.5 Microdermics Recent Developments
- 6.11 Lohmann Therapie-Systeme AG
- 6.11.1 Lohmann Therapie-Systeme AG Company Information
- 6.11.2 Lohmann Therapie-Systeme AG Business Overview
- 6.11.3 Lohmann Therapie-Systeme AG Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Lohmann Therapie-Systeme AG Skin Active Delivery System Product Portfolio
- 6.11.5 Lohmann Therapie-Systeme AG Recent Developments
- 6.12 BASF
- 6.12.1 BASF Company Information
- 6.12.2 BASF Business Overview
- 6.12.3 BASF Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 BASF Skin Active Delivery System Product Portfolio
- 6.12.5 BASF Recent Developments
- 6.13 3M
- 6.13.1 3M Company Information
- 6.13.2 3M Business Overview
- 6.13.3 3M Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 3M Skin Active Delivery System Product Portfolio
- 6.13.5 3M Recent Developments
- 6.14 Evonik Personal Care
- 6.14.1 Evonik Personal Care Company Information
- 6.14.2 Evonik Personal Care Business Overview
- 6.14.3 Evonik Personal Care Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Evonik Personal Care Skin Active Delivery System Product Portfolio
- 6.14.5 Evonik Personal Care Recent Developments
- 6.15 Vantage Personal Care
- 6.15.1 Vantage Personal Care Company Information
- 6.15.2 Vantage Personal Care Business Overview
- 6.15.3 Vantage Personal Care Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Vantage Personal Care Skin Active Delivery System Product Portfolio
- 6.15.5 Vantage Personal Care Recent Developments
- 6.16 Minerals Technologies
- 6.16.1 Minerals Technologies Company Information
- 6.16.2 Minerals Technologies Business Overview
- 6.16.3 Minerals Technologies Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Minerals Technologies Skin Active Delivery System Product Portfolio
- 6.16.5 Minerals Technologies Recent Developments
- 6.17 Bicosome
- 6.17.1 Bicosome Company Information
- 6.17.2 Bicosome Business Overview
- 6.17.3 Bicosome Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Bicosome Skin Active Delivery System Product Portfolio
- 6.17.5 Bicosome Recent Developments
7 North America
- 7.1 North America Skin Active Delivery System Market Size (2021-2032)
- 7.2 North America Skin Active Delivery System Market Size by Type
- 7.2.1 North America Skin Active Delivery System Market Size by Type (2021-2026)
- 7.2.2 North America Skin Active Delivery System Market Size by Type (2027-2032)
- 7.2.3 North America Skin Active Delivery System Market Share by Type (2021-2032)
- 7.3 North America Skin Active Delivery System Market Size by Application
- 7.3.1 North America Skin Active Delivery System Market Size by Application (2021-2026)
- 7.3.2 North America Skin Active Delivery System Market Size by Application (2027-2032)
- 7.3.3 North America Skin Active Delivery System Market Share by Application (2021-2032)
- 7.4 North America Skin Active Delivery System Market Size by Country
- 7.4.1 North America Skin Active Delivery System Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Skin Active Delivery System Market Size by Country (2021-2026)
- 7.4.3 North America Skin Active Delivery System Market Size by Country (2027-2032)
- 7.4.4 North America Skin Active Delivery System Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Skin Active Delivery System Market Size (2021-2032)
- 8.2 Europe Skin Active Delivery System Market Size by Type
- 8.2.1 Europe Skin Active Delivery System Market Size by Type (2021-2026)
- 8.2.2 Europe Skin Active Delivery System Market Size by Type (2027-2032)
- 8.2.3 Europe Skin Active Delivery System Market Share by Type (2021-2032)
- 8.3 Europe Skin Active Delivery System Market Size by Application
- 8.3.1 Europe Skin Active Delivery System Market Size by Application (2021-2026)
- 8.3.2 Europe Skin Active Delivery System Market Size by Application (2027-2032)
- 8.3.3 Europe Skin Active Delivery System Market Share by Application (2021-2032)
- 8.4 Europe Skin Active Delivery System Market Size by Country
- 8.4.1 Europe Skin Active Delivery System Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Skin Active Delivery System Market Size by Country (2021-2026)
- 8.4.3 Europe Skin Active Delivery System Market Size by Country (2027-2032)
- 8.4.4 Europe Skin Active Delivery System Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Skin Active Delivery System Market Size (2021-2032)
- 9.2 China Skin Active Delivery System Market Size by Type
- 9.2.1 China Skin Active Delivery System Market Size by Type (2021-2026)
- 9.2.2 China Skin Active Delivery System Market Size by Type (2027-2032)
- 9.2.3 China Skin Active Delivery System Market Share by Type (2021-2032)
- 9.3 China Skin Active Delivery System Market Size by Application
- 9.3.1 China Skin Active Delivery System Market Size by Application (2021-2026)
- 9.3.2 China Skin Active Delivery System Market Size by Application (2027-2032)
- 9.3.3 China Skin Active Delivery System Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Skin Active Delivery System Market Size (2021-2032)
- 10.2 Asia Skin Active Delivery System Market Size by Type
- 10.2.1 Asia Skin Active Delivery System Market Size by Type (2021-2026)
- 10.2.2 Asia Skin Active Delivery System Market Size by Type (2027-2032)
- 10.2.3 Asia Skin Active Delivery System Market Share by Type (2021-2032)
- 10.3 Asia Skin Active Delivery System Market Size by Application
- 10.3.1 Asia Skin Active Delivery System Market Size by Application (2021-2026)
- 10.3.2 Asia Skin Active Delivery System Market Size by Application (2027-2032)
- 10.3.3 Asia Skin Active Delivery System Market Share by Application (2021-2032)
- 10.4 Asia Skin Active Delivery System Market Size by Country
- 10.4.1 Asia Skin Active Delivery System Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Skin Active Delivery System Market Size by Country (2021-2026)
- 10.4.3 Asia Skin Active Delivery System Market Size by Country (2027-2032)
- 10.4.4 Asia Skin Active Delivery System Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Skin Active Delivery System Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Skin Active Delivery System Market Size by Type
- 11.2.1 South America, Middle East & Africa Skin Active Delivery System Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Skin Active Delivery System Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Skin Active Delivery System Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Skin Active Delivery System Market Size by Application
- 11.3.1 South America, Middle East & Africa Skin Active Delivery System Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Skin Active Delivery System Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Skin Active Delivery System Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Skin Active Delivery System Market Size by Country
- 11.4.1 South America, Middle East & Africa Skin Active Delivery System Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Skin Active Delivery System Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Skin Active Delivery System Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Skin Active Delivery System Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst